Covid-19 may have added significant uncertainty to the macroeconomic outlook but investments should still be made to lean into consumer trends proving robust – and Upfield Group’s spending on plant-based dairy R&D is one such move that looks sound, writes GlobalData.
Upfield Group, the Netherlands-based supplier of plant-based alternatives to dairy products, is stepping up its investment in research and development – and, despite the macroeconomic uncertainty wrought by Covid-19, it is the right time to spend.
The company, home to brands including I Can’t Believe It’s Not Butter dairy-free spreads and Violife plant-based cheese, is investing EUR50m (US$56.1m) into a new R&D centre in the Dutch town Wageningen.
The move emphasises the growth and attractiveness of the dairy-alternatives market – and it also underlines how competitive the category is becoming.
Upfield wants to use the facility to develop and launch more plant-based food products along with sustainable packaging solutions.
Amid the Covid-19 pandemic, it may seem a difficult time to invest but the sustained recent growth of the dairy-alternatives market should give businesses like Upfield confidence – as should the dynamics driving demand in recent weeks and the prospects for the category moving forward.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData
Consumer demand for dairy-free products has been steadily rising year-on-year to form a large and well-developed consumer cohort. Demand is largely driven by the perceived healthiness of plant-based diets. Whilst the vegan population worldwide is, in actual fact, rather small, more and more people are adopting low-meat or flexitarian diets. Whether due to health or dietary needs, or just personal choice, consumers who have switched to dairy-alternatives have largely maintained their buying habits.
Moreover, since the outbreak of Covid-19, there appears to have been an uptick in demand in certain markets.
According to GlobalData’s week 10 Covid-19 tracker consumer survey, published on 3 June, consumers in four major European markets (Sweden, Italy, the UK and Germany), when asked how their shopping behaviour has changed since the outbreak of Covid-19, 49% of consumers said they have been buying the same or more, plant-based dairy alternative products. This compared to 19% who stopped buying or are buying fewer dairy-alternative products.
This is why Upfield’s investment looks like a good idea. Demand for dairy-alternative products is only on the rise. Not only that, as consumer demand is relatively well developed, the near future will likely see demand go beyond a core product and more interest given to innovative new products within the space.
However, competition in the dairy-free sector is on the rise, with big names in dairy entering the category through M&A and innovation and venture-capital funds also placing bets on the category.
Furthermore, our research shows that, while Covid-19 is, for obvious reasons, front-and-centre in consumers’ minds, a range of factors continue to drive purchasing behaviour – and environmental concerns are holding their importance. Upfield’s investment in R&D around sustainable packaging also looks a good bet.